(Q51865158)

14 April 2018

title

Lower visual acuity predicts worse utility values among patients with type 2 diabetes. (English)

1 reference

14 April 2018

1 reference

David H Smith

1

1 reference

14 April 2018

Eric S Johnson

2

1 reference

14 April 2018

Allen Russell

3

1 reference

14 April 2018

Brian Hazlehurst

4

1 reference

14 April 2018

Cecilia Muraki

5

1 reference

14 April 2018

Gregory A Nichols

6

1 reference

14 April 2018

Allen Oglesby

7

1 reference

14 April 2018

Jonathan Betz-Brown

8

1 reference

14 April 2018

publication date

30 October 2008

1 reference

14 April 2018

published in

Quality of Life Research

1 reference

14 April 2018

volume

17

1 reference

14 April 2018

issue

10

1 reference

14 April 2018

page(s)

1277-1284

1 reference

14 April 2018

https://scigraph.springernature.com/pub.10.1007/s11136-008-9399-1

exact match

0 references

cites work

Utility values and age-related macular degeneration.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11136-008-9399-1

Converting visual acuity to utilities

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11136-008-9399-1

EuroQol: the current state of play

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11136-008-9399-1

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

21 January 2018

1 reference

12 December 2020

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

1 reference

12 December 2020

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

The estimation of a preference-based measure of health from the SF-36.

1 reference

12 December 2020

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

1 reference

12 December 2020

Valuing health-related quality of life in diabetes

1 reference

12 December 2020

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

12 December 2020

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

1 reference

12 December 2020

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

1 reference

12 December 2020

Important Causes of Visual Impairment in the World Today

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

12 December 2020

Utilities associated with diabetic retinopathy: results from a Canadian sample

1 reference

12 December 2020

Causes and prevalence of visual impairment among adults in the United States

1 reference

12 December 2020

MediClass: A system for detecting and classifying encounter-based clinical events in any electronic medical record

1 reference

12 December 2020

The impact of diabetic retinopathy: perspectives from patient focus groups

1 reference

12 December 2020

Case-control study of 10 years of comprehensive diabetes care

1 reference

12 December 2020

10.1007/S11136-008-9399-1

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018